{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T19:44:28Z","timestamp":1794599068662,"version":"4.9.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["EY07366"],"award-info":[{"award-number":["EY07366"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Research to Prevent Blindness, Inc"},{"name":"Heed Ophthalmic Fellowship, Heed Foundation"},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Geneneron"},{"name":"Sirion"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.ajo.2009.10.019","type":"journal-article","created":{"date-parts":[[2010,2,19]],"date-time":"2010-02-19T04:17:40Z","timestamp":1266553060000},"page":"433-440.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Viral Retinitis After Intravitreal Triamcinolone Injection in Patients With Predisposing Medical Comorbidities"],"prefix":"10.1016","volume":"149","author":[{"given":"Ankur M.","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen F.","family":"Oster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2009.10.019_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00004397-200604620-00010","article-title":"Cytomegalovirus retinitis","volume":"46","author":"Wiegand","year":"2006","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.ajo.2009.10.019_bib2","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ajo.2004.04.015","article-title":"Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection","volume":"138","author":"Kuo","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.10.019_bib3","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1086\/318447","article-title":"Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation","volume":"32","author":"Crippa","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajo.2009.10.019_bib4","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0002-9394(02)01978-5","article-title":"Progressive outer retinal necrosis in immunocompetent patients treated initially for optic neuropathy with systemic corticosteroids","volume":"135","author":"Benz","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.10.019_bib5","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0002-9394(03)00095-3","article-title":"Acute retinal necrosis following epidural steroid injections","volume":"136","author":"Browning","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.10.019_bib6","first-page":"1","article-title":"Necrotizing herpetic retinopathies","volume":"26","author":"Goldstein","year":"2008","journal-title":"Focal Points: Clinical Modules for Ophthalmologists"},{"key":"10.1016\/j.ajo.2009.10.019_bib7","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0002-9394(86)90396-X","article-title":"Demonstration of herpes group virus in acute retinal necrosis syndrome","volume":"102","author":"Freeman","year":"1986","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.10.019_bib8","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.ajo.2005.06.058","article-title":"Cytomegalovirus retinitis after intravitreal triamcinolone in an immunocompetent patient","volume":"140","author":"Saidel","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.10.019_bib9","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1600-0420.2007.00915.x","article-title":"Cytomegalovirus retinitis following intravitreal injection of triamcinolone: report of two cases","volume":"85","author":"Delyfer","year":"2007","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ajo.2009.10.019_bib10","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ajo.2006.09.020","article-title":"Cytomegalovirus retinitis after fluocinolone acetonide (Retisert\u2122) implant","volume":"143","author":"Ufret-Vincenty","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.10.019_bib11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000090579","article-title":"Endophthalmitis with retinal necrosis following intravitreal triamcinolone acetonide injection","volume":"220","author":"Aggermann","year":"2006","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.ajo.2009.10.019_bib12","first-page":"380","article-title":"Acute retinal necrosis post intravitreal injection of triamcinolone acetonide","author":"Toh","year":"2006"},{"key":"10.1016\/j.ajo.2009.10.019_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3341\/kjo.2008.22.2.143","article-title":"Cytomegalovirus retinitis after intravitreal triamcinolone injection in a patient with central retinal vein occlusion","volume":"22","author":"Park","year":"2008","journal-title":"Korean J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.10.019_bib14","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s10384-008-0576-0","article-title":"Cytomegalovirus retinitis after intravitreal triamcinolone acetonide in an immunocompetent patient","volume":"52","author":"Sekiryu","year":"2008","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.10.019_bib15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archopht.121.1.57","article-title":"Intravitreal injection of triamcinolone for the treatment of diffuse diabetic macular edema","volume":"121","author":"Jonas","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2009.10.019_bib16","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0002-9394(03)00230-7","article-title":"Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema","volume":"136","author":"Jonas","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.10.019_bib17","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0161-6420(00)00658-8","article-title":"Intravitreal triamcinolone for uveitis cystoid macular edema: an optical coherence tomography study","volume":"108","author":"Antcliff","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2009.10.019_bib18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0002-9394(03)00228-9","article-title":"Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion","volume":"136","author":"Park","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.10.019_bib19","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ajo.2004.06.067","article-title":"Intravitreal triamcinolone acetonide and intraocular pressure","volume":"138","author":"Smithen","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.10.019_bib20","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.ophtha.2008.06.015","article-title":"A randomized trial comparing intravitreal triamcinolone acetonide and focal\/grid photocoagulation for diabetic macular edema","volume":"115","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2009.10.019_bib21","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0002-9394(01)01322-8","article-title":"Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy","volume":"133","author":"Jabs","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.10.019_bib22","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ophtha.2006.07.013","article-title":"Intravitreal triamcinolone acetonide for the treatment of immune recovery uveitis macular edema","volume":"114","author":"Morrison","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2009.10.019_bib23","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1080\/00365540260348644","article-title":"Reactivation of CMV retinitis after treatment with subtenon's corticosteroids for immune recovery uveitis in a patient with AIDS","volume":"34","author":"Dalessandro","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ajo.2009.10.019_bib24","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/00006982-200206000-00002","article-title":"Paradoxical activity of CMV retinitis in patients receiving highly active antiretroviral therapy","volume":"22","author":"Song","year":"2002","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2009.10.019_bib25","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0140-6736(96)11431-8","article-title":"Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy","volume":"349","author":"Jacobson","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ajo.2009.10.019_bib26","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/jac\/41.6.666","article-title":"Relapse of CMV retinitis in an AIDS patient with high CD4 counts","volume":"41","author":"Petit","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajo.2009.10.019_bib27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/095646249400500119","article-title":"HIV-associated CMV retinitis occurring in the setting of a high CD4 count: what about AIDS definitions?","volume":"5","author":"Angus","year":"1994","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.ajo.2009.10.019_bib28","first-page":"S873","article-title":"Progression of cytomegaloviral retinitis in a patient responding to highly active antiretroviral therapy","volume":"40","author":"Frame","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2009.10.019_bib29","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0002-9394(03)00483-5","article-title":"Acute endophthalmitis following intravitreal triamcinolone acetonide injection","volume":"136","author":"Moshfeghi","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.10.019_bib30","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/IAE.0b013e3181884fd2","article-title":"Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab","volume":"28","author":"Fintak","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2009.10.019_bib31","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00006982-200603000-00014","article-title":"Intravitreal toxicity of the Kenalog vehicle (benzyl alcohol) in rabbits","volume":"26","author":"Morrison","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2009.10.019_bib32","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/bjo.2007.126227","article-title":"Comparison of 4 mg versus 20 mg intravitreal triamcinolone acetonide injections","volume":"92","author":"Tammewar","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.10.019_bib33","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ajo.2003.08.012","article-title":"Intraocular availability of triamcinolone acetonide after intravitreal injection","volume":"137","author":"Jonas","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.10.019_bib34","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1136\/bjo.86.12.1450-a","article-title":"Concentration of intravitreally injected triamcinolone acetonide in intraocular silicone oil","volume":"86","author":"Jonas","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.10.019_bib35","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/bjo.2005.088278","article-title":"Photographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomised eye","volume":"90","author":"Kosobucki","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.10.019_bib36","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0161-6420(02)01969-3","article-title":"Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection","volume":"110","author":"Beer","year":"2003","journal-title":"Ophthalmology"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939409008022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939409008022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:00:43Z","timestamp":1757595643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939409008022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0002939409008022"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2009.10.019","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Viral Retinitis After Intravitreal Triamcinolone Injection in Patients With Predisposing Medical Comorbidities","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2009.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}